FirmAtlas
Company handbook · NDSN · Prepared by FirmAtlas · firmatlas.app · printed 2026-10-16
NDSN · CIK 72331 · LATEST FILING: 10-Q JUL '26 · FILED AUG 20, 2026
NORDSON CORPORATION
$322.31
−6.49 (−1.97%)
Close, Oct 16, 2026 · 52-week $223–339
Last fiscal year
NORDSON CORPORATION reported revenue of $2.8B for the year ended Oct 31, 2025 (FY25), up 3.8% from FY24. Net income was $484M, operating cash flow $719M and free cash flow $661M. Source: 10-K filed Dec 17, 2025.
Market cap
$18.0B
P/E
32.5
EV/EBITDA
25.6x
P/B
5.5
Div yield
1.05%
ROIC
11.1%
Revenue 1Y
3.8%/yr
EPS 1Y
4.9%/yr
Shares 1Y
−2%
Loading chart…
Median
Daily closes, split-adjusted · ratios at each fiscal year end
Company
CEOSundaram Nagarajan
HQWestlake, OH
AuditorErnst & Young LLP"
Employees8,000
Year endsOctober
Revenue by segment · FY25
Adhesive Dispensing Systems48%
Medical Fluid Systems30%
Advanced Technology Systems22%
Compounded growth & averages
10Y
5Y
3Y
TTM
Share price
12.9%
5.7%
12.8%
38.9%
Upgrade to see 10 years
Share price: yearly compound rate of the traded close; the last column is the past year.
Where the cash went · FY24–FY25
$13M deployed
Capex
$122M
965.3%
Dividends
$341M
2683.9%
Buybacks
$340M
2677.6%
Operating cash flow over the period: $1.3B. Total debt changed by +$20M. R&D of $133M is already inside operating costs.
Growth engines
How much of the profit growth came from new investment, and how much from running the business better.
Upgrade to see 10 years
Financials
Last 2 years · Upgrade to see 10 years · USD millions · each year opens its 10-K · FY25 = year ended Oct 31, 2025 · change vs previous year
Last 4 quarters · USD millions · quarter-end month shown · change vs same quarter a year earlier
TTM = the last four quarters, to Jul '26. Balance-sheet rows show that latest quarter. “—” where the quarters do not add up to the annual figures. No TTM for cash: our quarterly rows do not hold short-term investments yet, and annual cash includes them.
Income
Revenue
2,690
2,792+3.8%
2,980
YoY
+3.8%
Gross profit
1,486
1,540+3.6%
1,647
Gross margin
55.2%
55.2%−0.1 pp
—
Operating income
674
712+5.6%
801
Operating margin
25.1%
25.5%+0.4 pp
—
EBITDA
751
791+5.3%
—
EBITDA margin
27.9%
28.3%+0.4 pp
—
Interest expense
89
104+17.1%
—
Interest coverage
8.45x
7.59x−0.85x
—
Net income
467
484+3.7%
555
YoY
+3.7%
Net margin
17.4%
17.4%−0.0 pp
—
EPS (diluted, $)
8.11
8.51+4.9%
9.91
YoY
+4.9%
Balance sheet
Total assets
6,001
5,918−1.4%
5,948
Cash & short-term investments
116
108−6.5%
—
Accounts receivable
595
588−1.1%
—
Inventory
477
445−6.7%
—
Net PP&E
545
517−5.1%
—
Other assets
4,269
4,260−0.2%
—
Total liabilities
3,069
2,874−6.3%
2,679
Accounts payable
98
121+23.7%
—
Total debt
2,291
2,311+0.9%
1,923
Other liabilities
680
442−35.0%
—
Shareholders’ equity
2,932
3,044+3.8%
3,269
Total liabilities = total assets − shareholders’ equity, so it includes minority interest where a company has one.
Cash flow statement · as filed
Cash from operations
556
719+29.3%
773
Net income
467
484+3.7%
—
Depreciation & amortization
77
79+3.0%
—
Stock-based compensation
19
19−0.1%
—
Working capital & other
(7)
136n/m
—
Cash from investing
(844)
(27)n/m
—
Capex
(64)
(58)n/m
—
PP&E sold
0.1
0.3+312.0%
—
Acquisitions
790
—
—
Other investing
(1,570)
31n/m
—
Cash from financing
294
(706)−339.9%
—
Debt raised
783
26−96.7%
—
Debt repaid
(319)
(250)n/m
—
Dividends
(161)
(179)n/m
—
Buybacks
(33)
(306)n/m
—
Shares issued
31
9−71.0%
—
Other financing
(6)
(6)n/m
—
Net change in cash
0.3
(8)−2850.9%
—
Free cash flow (OCF − capex)
492
661+34.4%
724
Where the cash went
Operating cash flow
556
719+29.3%
773
Reinvested in the business
(726)
58n/m
—
% of operating cash flow
-130.5%
8.1%
Capex
64
58−9.9%
49
Acquisitions
(790)
—
—
R&D (memo, already in costs)
65
68+5.0%
—
Free cash flow
492
661+34.4%
724
YoY
+34.4%
Returned to shareholders
195
485+149.2%
—
% of free cash flow
39.6%
73.4%
Dividends
161
179+10.9%
—
Buybacks
33
306+818.9%
—
Change in total debt
—
20
—
Cash left over
—
196
—
FCF conversion (FCF ÷ net income)
105.2%
136.5%+31.2 pp
—
Owner earnings
—
568
—
Owner earnings margin
—
20.3%
—
Buyback yield
0.2%
2.4%+2.1 pp
—
Returns & ratios
ROIC (all capital)
10.5%
11.1%+0.6 pp
—
ROIC (operating)
35.4%
39.2%+3.7 pp
—
Net debt / EBITDA
2.90x
2.78x−0.11x
—
Debt / equity
0.78x
0.76x−0.02x
—
Cash conversion cycle (days)
196
171−24 d
—
ROE
15.9%
15.9%−0.0 pp
—
ROA
7.8%
8.2%+0.4 pp
—
ROCE
12.3%
13.8%+1.5 pp
—
NOPAT
538
577+7.3%
—
Invested capital (operating)
1,518
1,429−5.9%
—
Invested capital (all)
5,107
5,246+2.7%
—
Reinvestment rate
—
−15.6%
—
Debtor days
81
77−4 d
—
Inventory days
145
130−15 d
—
Days payable
30
35+6 d
—
Income
Oct '25
Jan '26
Apr '26
Jul '26
Revenue
752
669
741
818
vs year-ago quarter
Gross profit
423
366
404
454
Gross margin
56.3%
54.7%
54.5%
55.5%
Operating income
214
166
197
223
Net income
152
133
117
153
vs year-ago quarter
Net margin
20.2%
19.9%
15.8%
18.7%
EPS (diluted, $)
2.71
2.38
2.09
2.73
vs year-ago quarter
Balance sheet
Oct '25
Jan '26
Apr '26
Jul '26
Total assets
5,918
5,961
5,964
5,948
Cash & equivalents
108
120
102
113
Total debt
2,311
2,038
1,930
1,923
Shareholders’ equity
3,044
3,112
3,202
3,269
Cash flow
Oct '25
Jan '26
Apr '26
Jul '26
Operating cash flow
203
140
181
249
Capex
9
18
10
13
Free cash flow
194
123
170
237
vs year-ago quarter